ES2177625T3 - Citoquina cc-1 humana circulante. - Google Patents

Citoquina cc-1 humana circulante.

Info

Publication number
ES2177625T3
ES2177625T3 ES95905105T ES95905105T ES2177625T3 ES 2177625 T3 ES2177625 T3 ES 2177625T3 ES 95905105 T ES95905105 T ES 95905105T ES 95905105 T ES95905105 T ES 95905105T ES 2177625 T3 ES2177625 T3 ES 2177625T3
Authority
ES
Spain
Prior art keywords
cytoquine
circulating human
derivatives
circulating
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95905105T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Peter Schulz-Knappe
Markus Meyer
Hans-Jurgen Magert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19934344397 external-priority patent/DE4344397A1/de
Priority claimed from DE19944427395 external-priority patent/DE4427395A1/de
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2177625T3 publication Critical patent/ES2177625T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

CITOQUINA CC-1 CON LA SIGUIENTE SECUENCIA DE AMINOACIDOS SEGUN SEC. ID N OGICAMENTE ACTIVOS, ESPECIALMENTE AMIDADOS, ACETILADOS, FOSFORILADOS Y/O GLICOSILADOS.
ES95905105T 1993-12-24 1994-12-22 Citoquina cc-1 humana circulante. Expired - Lifetime ES2177625T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19934344397 DE4344397A1 (de) 1993-12-24 1993-12-24 Humanes zirkulierendes Cytokin CC-1
DE19944427395 DE4427395A1 (de) 1994-08-03 1994-08-03 Humanes zirkulierendes Cytokin CC-1

Publications (1)

Publication Number Publication Date
ES2177625T3 true ES2177625T3 (es) 2002-12-16

Family

ID=25932491

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95905105T Expired - Lifetime ES2177625T3 (es) 1993-12-24 1994-12-22 Citoquina cc-1 humana circulante.

Country Status (9)

Country Link
US (3) US20030105293A1 (es)
EP (1) EP0736095B1 (es)
JP (1) JP3630685B2 (es)
AT (1) ATE218616T1 (es)
AU (1) AU680714B2 (es)
CA (1) CA2179638A1 (es)
DE (1) DE59410132D1 (es)
ES (1) ES2177625T3 (es)
WO (1) WO1995018228A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
US5602008A (en) * 1994-11-29 1997-02-11 Incyte Pharmaceuticals, Inc. DNA encoding a liver expressed chemokine
KR19990008335A (ko) * 1995-05-05 1999-01-25 로버트 에리치. 벤슨 인체 케모킨 베타-8, 케모킨 베타-1 및 대식세포 염증 단백질-4
DE69631253T2 (de) * 1995-10-24 2004-11-18 Human Genome Sciences, Inc. Mobilisierung von haematopoietischen stammzellen durch ein chemokin
US6713052B1 (en) 1995-10-24 2004-03-30 Human Genome Sciences, Inc. Method of mobilizing stem cells with chemokine β-8
EP1422239A3 (en) * 1995-10-24 2004-12-01 Smithkline Beecham Corporation Mobilization of hematopoietic stem cells using a chemokine
ES2256885T3 (es) 1996-04-30 2006-07-16 Pharis Biotec Gmbh Nuevas quimiocinas del tipo cc.
CN1239510A (zh) * 1996-09-30 1999-12-22 人类基因组科学公司 用髓先祖抑制因子-1、单核细胞集落抑制因子和巨噬细胞抑制因子-4治疗疾病的组合物和方法
EP1167527A1 (en) * 2000-06-22 2002-01-02 Euroscreen S.A. Processed human chemokines PHC-1 and PHC-2
DE60030749T2 (de) * 1999-10-25 2007-09-20 Pharis Biotec Gmbh Prozessiertes menschliches chemokin phc-1
EP1675870A1 (en) * 2003-10-24 2006-07-05 IPF Pharmaceuticals GmbH Human chemokine hcc-1 polypeptides to improve stem cell transplantation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US6057123A (en) * 1991-12-23 2000-05-02 British Biotech Pharmaceuticals Limited Stem cell inhibiting proteins

Also Published As

Publication number Publication date
US20030105293A1 (en) 2003-06-05
US20050106678A1 (en) 2005-05-19
JP3630685B2 (ja) 2005-03-16
EP0736095B1 (de) 2002-06-05
AU680714B2 (en) 1997-08-07
AU1384995A (en) 1995-07-17
CA2179638A1 (en) 1995-07-06
US20080234187A1 (en) 2008-09-25
JPH09510084A (ja) 1997-10-14
EP0736095A1 (de) 1996-10-09
WO1995018228A1 (de) 1995-07-06
DE59410132D1 (de) 2002-07-11
ATE218616T1 (de) 2002-06-15

Similar Documents

Publication Publication Date Title
DE69514342T2 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
ES2177625T3 (es) Citoquina cc-1 humana circulante.
DE69731373D1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
TR199901754T2 (xx) Helicobacter pylori enfeksiyonlar�n�n ve bunlarla ba�lant�l� gastro-duodenal rahats�zl�klar�n tedavisinde
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
IS2518B (is) Lífvirk peptíð, not fyrir þau og vinnsla þeirra
NO940299L (no) Peptid med organbeskyttende aktivitet
DK0759775T3 (da) Flydende IFN-beta-formuleringer
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
ITRM930291A0 (it) Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
MC1884A1 (fr) Variants de l'hirudine,leur utilisation et leur preparation
ES2058479T3 (es) Compuestos peptidicos.
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
DK1040191T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
BR8700693A (pt) Expelentes de microbios fitopatogenicos e composicao expelente de microbios fitopatogenicos
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE69736325D1 (de) Cr1 fragmente und deren verwendung
RU96103721A (ru) Антгельминтное средство
IT8620345A0 (it) Vettore plasmidico ad espressione in bacillus utile per il clonaggio del genestrutturale che codifica per l'ormone della crescita umano e procedimento per la produzione didetto ormone.